Literature DB >> 26453172

Size selectivity of intestinal mucus to diffusing particulates is dependent on surface chemistry and exposure to lipids.

Hasan M Yildiz1, Craig A McKelvey2, Patrick J Marsac2, Rebecca L Carrier1.   

Abstract

Intestinal mucus provides a significant barrier to transport of orally delivered drug carriers, as well as other particulates (e.g. food, microbes). The relative significance of particle size, surface chemistry, and dosing medium to mucus barrier properties is not well characterized, but important in designing delivery systems targeted to the intestinal mucosa. In this study, multiple particle tracking (MPT) was used to study diffusion of 20-500 nm diameter carboxylate- and polyethylene glycol-(PEG-)functionalized polystyrene model carriers through intestinal mucus. The impact of exposure to mucus in buffer versus a partially digested triglyceride mixture was explored. Effective diffusivity of particles in intestinal mucus decreased with an increasing particle size less than and more than theoretically (Stokes-Einstein) expected in a homogenous medium when dosed in buffer and model-fed state intestinal contents, respectively. For example, effective diffusivity decreased 2.9- versus 20-fold with increase in the particle size from 100 to 500 nm when dosed to mucus in buffer versus lipid-containing medium. Functionalization with PEG dramatically decreased sensitivity to lipids in a dosing medium. The results indicate that reduction of particle size may increase particle transport through intestinal mucus barriers, but these effects are strongly dependent on intestinal contents and particle surface chemistry.

Entities:  

Keywords:  Diffusion; intestine; lipids; nanoparticles; oral drug delivery; particle transport

Mesh:

Substances:

Year:  2015        PMID: 26453172      PMCID: PMC4874559          DOI: 10.3109/1061186X.2015.1086359

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  34 in total

1.  Diffusion of macromolecules and virus-like particles in human cervical mucus.

Authors:  S S Olmsted; J L Padgett; A I Yudin; K J Whaley; T R Moench; R A Cone
Journal:  Biophys J       Date:  2001-10       Impact factor: 4.033

2.  Examination of the solubilization of drugs by bile salt micelles.

Authors:  Timothy Scott Wiedmann; Lamya Kamel
Journal:  J Pharm Sci       Date:  2002-08       Impact factor: 3.534

3.  Enhanced viscoelasticity of human cystic fibrotic sputum correlates with increasing microheterogeneity in particle transport.

Authors:  Michelle Dawson; Denis Wirtz; Justin Hanes
Journal:  J Biol Chem       Date:  2003-09-17       Impact factor: 5.157

4.  Gastric surfactant and the hydrophobic mucosal barrier.

Authors:  B A Hills
Journal:  Gut       Date:  1996-11       Impact factor: 23.059

Review 5.  Single-particle tracking: applications to membrane dynamics.

Authors:  M J Saxton; K Jacobson
Journal:  Annu Rev Biophys Biomol Struct       Date:  1997

6.  The influence of intestinal mucus components on the diffusion of drugs.

Authors:  A W Larhed; P Artursson; E Björk
Journal:  Pharm Res       Date:  1998-01       Impact factor: 4.200

7.  Effect of lipids and proteins on the viscosity of gastric mucus glycoprotein.

Authors:  V L Murty; J Sarosiek; A Slomiany; B L Slomiany
Journal:  Biochem Biophys Res Commun       Date:  1984-06-15       Impact factor: 3.575

8.  Nasal absorption of insulin: enhancement by hydrophobic bile salts.

Authors:  G S Gordon; A C Moses; R D Silver; J S Flier; M C Carey
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

9.  Real-time intracellular transport of gene nanocarriers studied by multiple particle tracking.

Authors:  Junghae Suh; Denis Wirtz; Justin Hanes
Journal:  Biotechnol Prog       Date:  2004 Mar-Apr

10.  The influence of small intestinal mucus structure on particle transport ex vivo.

Authors:  Balázs H Bajka; Neil M Rigby; Kathryn L Cross; Adam Macierzanka; Alan R Mackie
Journal:  Colloids Surf B Biointerfaces       Date:  2015-07-19       Impact factor: 5.268

View more
  18 in total

1.  Understanding Mechanisms of Food Effect and Developing Reliable PBPK Models Using a Middle-out Approach.

Authors:  Xavier J H Pepin; James E Huckle; Ravindra V Alluri; Sumit Basu; Stephanie Dodd; Neil Parrott; Arian Emami Riedmaier
Journal:  AAPS J       Date:  2021-01-04       Impact factor: 4.009

Review 2.  Nanoparticles for oral delivery: Design, evaluation and state-of-the-art.

Authors:  Abhijit A Date; Justin Hanes; Laura M Ensign
Journal:  J Control Release       Date:  2016-06-09       Impact factor: 9.776

3.  Tuning the PEG surface density of the PEG-PGA enveloped Octaarginine-peptide Nanocomplexes.

Authors:  Eleni Samaridou; Nikolaos Kalamidas; Irene Santalices; José Crecente-Campo; Maria José Alonso
Journal:  Drug Deliv Transl Res       Date:  2020-02       Impact factor: 4.617

Review 4.  Engineering the Mucus Barrier.

Authors:  T L Carlson; J Y Lock; R L Carrier
Journal:  Annu Rev Biomed Eng       Date:  2018-06-04       Impact factor: 9.590

5.  Lipids alter microbial transport through intestinal mucus.

Authors:  Taylor L Carlson; Hasan Yildiz; Zaineb Dar; Jaclyn Y Lock; Rebecca L Carrier
Journal:  PLoS One       Date:  2018-12-21       Impact factor: 3.240

6.  Molecular targeting of FATP4 transporter for oral delivery of therapeutic peptide.

Authors:  Zhenhua Hu; Sara Nizzero; Shreya Goel; Louis E Hinkle; Xiaoyan Wu; Chao Li; Mauro Ferrari; Haifa Shen
Journal:  Sci Adv       Date:  2020-04-01       Impact factor: 14.136

Review 7.  Current approaches in lipid-based nanocarriers for oral drug delivery.

Authors:  María Plaza-Oliver; Manuel Jesús Santander-Ortega; María Victoria Lozano
Journal:  Drug Deliv Transl Res       Date:  2021-02-02       Impact factor: 4.617

8.  High-fat diet-induced upregulation of exosomal phosphatidylcholine contributes to insulin resistance.

Authors:  Anil Kumar; Kumaran Sundaram; Jingyao Mu; Gerald W Dryden; Mukesh K Sriwastva; Chao Lei; Lifeng Zhang; Xiaolan Qiu; Fangyi Xu; Jun Yan; Xiang Zhang; Juw Won Park; Michael L Merchant; Henry C L Bohler; Baomei Wang; Shuangqin Zhang; Chao Qin; Ziying Xu; Xianlin Han; Craig J McClain; Yun Teng; Huang-Ge Zhang
Journal:  Nat Commun       Date:  2021-01-11       Impact factor: 14.919

9.  Oral delivery of metformin by chitosan nanoparticles for polycystic kidney disease.

Authors:  Jonathan Wang; Deborah Chin; Christopher Poon; Valeria Mancino; Jessica Pham; Hui Li; Pei-Yin Ho; Kenneth R Hallows; Eun Ji Chung
Journal:  J Control Release       Date:  2020-10-28       Impact factor: 9.776

10.  Acute Exposure to Commonly Ingested Emulsifiers Alters Intestinal Mucus Structure and Transport Properties.

Authors:  Jaclyn Y Lock; Taylor L Carlson; Chia-Ming Wang; Albert Chen; Rebecca L Carrier
Journal:  Sci Rep       Date:  2018-07-03       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.